IotaMotion Announces Issuance of New U.S. Patent

iotaMotion, Inc. has announced the issuance of U.S. Patent No. 12,558,123, further strengthening its intellectual property portfolio in robotic-assisted cochlear implantation.

“This new patent augments our strong intellectual property portfolio, which broadly covers systems and methods related to robotic positioning and control in cochlear implant surgery,” said Mike Lobinsky, CEO of iotaMotion. “As iotaSOFT becomes increasingly integrated across leading cochlear implant centers, protecting the technologies that standardize and control electrode insertion is central to sustaining our leadership in the field.”

The iotaSOFT Insertion System advances surgery beyond the limits of the human hand with consistent and controlled electrode insertion that preserves delicate intracochlear structures. The system is FDA cleared for patients four years of age and older and is commercially available in the United States.

According to the World Health Organization, more than 430 million people globally experience disabling hearing loss, including over 60 million individuals who may benefit from cochlear implantation, yet fewer than 5% of eligible patients worldwide receive an implant. As robotic-assisted technology continues to gain clinical adoption, intellectual property strength plays a critical role in enabling sustained innovation and long-term advancement within the field.

Source: IotaMotion, Inc.

The post IotaMotion Announces Issuance of New U.S. Patent appeared first on Surgical Robotics Technology.